Adherent Invasive E. coli (AIEC)

AIEC stands as a particular E. coli strain which shows strong connection to inflammatory bowel disease (IBD) through its association with Crohn's disease. AIEC differs from standard E. coli because it demonstrates targeted adherence to intestinal epithelial cells followed by cell invasion and intracellular survival and multiplication without immediate host cell death. The ability of AIEC to survive inside host cells enables it to avoid immune system detection while producing ongoing inflammation that leads to persistent intestinal inflammation. Research indicates AIEC exists more commonly in ileal tissue of Crohn's disease patients than in normal tissue samples which suggests its involvement in disease development.

Characteristics of AIEC

Adhesion to Intestinal Epithelial Cells

The primary characteristic of AIEC bacteria is their strong ability to bind to intestinal epithelial cells. The bacterial adhesins on AIEC enable them to bind to host receptors which results in their ability to adhere to intestinal epithelial cells. The ileal epithelial cells of Crohn's disease patients express elevated levels of carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) which serves as a receptor for AIEC to establish selective colonization. The receptor-ligand connection between AIEC and CEACAM6 leads to better bacterial survival and extended mucosal colonization.

Host Cell Invasion

The bacteria establish contact with epithelial cells before they penetrate these cells through endocytic pathways. The invasion process of AIEC into epithelial cells occurs through endocytic pathways without causing major cell death to the host cells. The bacteria find a suitable environment inside host cell cytoplasm to multiply and create intracellular habitats.

Survival in Macrophages

AIEC bacteria demonstrate a unique ability to survive and multiply inside macrophages which makes them stand out from other bacteria. The normal process of phagocytosis leads bacteria to destruction by lysosomal enzymes. The bacteria manage to evade lysosomal destruction by multiplying inside the immune cells. The bacteria create a continuous inflammatory response in the intestinal mucosa through their ability to activate macrophages which produce pro-inflammatory cytokines.

Detection and Research Methods

The detection of AIEC involves three main approaches which include functional phenotyping and molecular marker analysis and serological testing. The traditional cell-line phenotypic screening method using Caco-2, HT-29 and T84 cell lines assesses bacterial pathogenicity through adhesion and invasion and intracellular replication in macrophages and serves as the primary gold-standard assay. The development of PCR/qPCR assays for specific genes including fimH and pic and predictive models using 10-20 AIEC-specific SNPs has improved the speed of molecular identification for extensive strain collections. Clinically, measuring IgG antibodies against total E. coli in patient serum (AEcAb) with a defined cutoff provides a non‑invasive screening tool with a negative predictive value of 96.6 %; when combined with total E. coli counts in stool or biopsy specimens and an invasion threshold (>60 CFU per biopsy), the negative predictive value reaches 94.1 %. Additionally, MOS‑functionalized microgels that specifically bind the FimH adhesin can capture and remove AIEC ex‑vivo, offering both detection and "drug‑free" decontamination capabilities. Finally, high‑throughput genetic screens (e.g., type IV secretion system, gene knock‑outs) identify essential virulence genes, further refining molecular markers. By integrating these approaches, researchers can achieve precise identification and monitoring of AIEC across laboratory studies, clinical screening, and potential therapeutic strategies.